Related Experiment Video
Updated: Aug 16, 2026
03:57
Electrochemotherapy of Tumours
Published on: December 15, 2008
Abstract:
The search for more effective drugs and treatment modalities is being effectively tested by the cooperative oncology groups. The mechanism employed is that of prospective controlled randomized clinical trials. This approach has proved to be a rapid and efficient means of comparing treatments in comparable patients. These clinical trials are the testing grounds for the new discoveries that are expected to improve the treatment of melanoma and other cancers.
Insights
Cooperative oncology groups use randomized clinical trials to rapidly test new cancer treatments. These trials efficiently compare therapies for patients, advancing discoveries for melanoma and other cancers.
Area of Science:
- Oncology
- Clinical Pharmacology
Background:
- Cooperative oncology groups are instrumental in advancing cancer treatment research.
- The development of novel therapeutic agents and treatment strategies is crucial for improving patient outcomes.
Purpose of the Study:
- To highlight the role of cooperative oncology groups in evaluating new cancer drugs and treatment modalities.
- To emphasize the efficiency and effectiveness of prospective controlled randomized clinical trials in cancer research.
Main Methods:
- Prospective controlled randomized clinical trials are the primary methodology employed.
- This approach facilitates the comparison of different treatment options in well-defined patient populations.
Main Results:
- Randomized clinical trials provide a rapid and efficient means of comparing therapeutic interventions.
- These trials serve as critical platforms for validating new discoveries in cancer treatment.
Conclusions:
- Cooperative oncology groups effectively utilize randomized clinical trials to test novel cancer therapies.
- This methodology accelerates the discovery and validation of treatments aimed at improving outcomes for melanoma and other cancers.
Related Concept Videos
02:17The Tumor Microenvironment
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
02:49Cancer Therapies
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
02:50Combination Therapies and Personalized Medicine
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
01:30Skin Cancer
Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
01:27Tumor Immunotherapy
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.